María Esther
Larrea Leoz
Catedrática de Universidad
Pablo
Sarobe Ugarriza
Catedrático de Universidad
Publicacions en què col·labora amb Pablo Sarobe Ugarriza (10)
2016
-
Gene expression analysis during acute hepatitis C virus infection associates dendritic cell activation with viral clearance
Journal of Medical Virology, Vol. 88, Núm. 5, pp. 843-851
2015
-
Clinical testing of a dendritic cell targeted therapeutic vaccine in patients with chronic hepatitis C virus infection
Molecular Therapy - Methods and Clinical Development, Vol. 2, pp. 15006
2014
-
Characterization of the CD40L/Oncostatin M/Oncostatin M receptor axis as an antiviral and immunostimulatory system disrupted in chronic HCV infection
Journal of Hepatology, Vol. 60, Núm. 3, pp. 482-489
-
Dysregulation of interferon regulatory factors impairs the expression of immunostimulatory molecules in hepatitis C virus genotype 1-infected hepatocytes
Gut, Vol. 63, Núm. 4, pp. 665-673
2013
-
A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis C
Journal of Hepatology, Vol. 59, Núm. 1, pp. 81-88
2011
-
Hepatitis C virus induces the expression of CCL17 and CCL22 chemokines that attract regulatory T cells to the site of infection
Journal of Hepatology, Vol. 54, Núm. 3, pp. 422-431
-
Improved dendritic cell-based immunization against hepatitis C virus using peptide inhibitors of interleukin 10
Hepatology, Vol. 53, Núm. 1, pp. 23-31
2009
-
Oncostatin M enhances the antiviral effects of type I interferon and activates immunostimulatory functions in liver epithelial cells
Journal of Virology, Vol. 83, Núm. 7, pp. 3298-3311
2007
-
Upregulation of indoleamine 2,3-dioxygenase in hepatitis C virus infection
Journal of Virology, Vol. 81, Núm. 7, pp. 3662-3666
1993
-
Enhancement of peptide immunogenicity by insertion of a cathepsin B cleavage site between determinants recognized by B and T cells
Research in Immunology, Vol. 144, Núm. 4, pp. 257-262